Serious adverse events related to transcatheter aortic valve replacement are infrequent: FORWARD 3‐years

Key Points Long‐term information about clinical events related to transcatheter aortic valve replacement (TAVR) is needed to be considered in younger populations. The overall rate of endocarditis, reintervention, and clinical valve thrombosis was low at 3 years. These results highlight that adverse events related to TAVR are infrequent at intermediate follow‐up and support the use of TAVR in clinical practice.